Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 20Thoracic 6Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 23Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 5Lung Neoplasms 4Breast Neoplasms, Male 3Stomach Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Mesothelioma 2Melanoma 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Sarcoma 1Salivary Gland Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1NSCLC 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Fallopian Tube Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Magnetic Resonance Spectroscopy 6Spinal Puncture 5Specimen Handling 5Methotrexate 3Trastuzumab 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2trastuzumab deruxtecan 1tipifarnib 1sacituzumab govitecan 1paclitaxel-Angiopep-2 conjugate 1merphos 1eribulin 1epothilone B 1Vinorelbine 1Sorafenib 1Referral and Consultation 1Radiation 1Probability 1Physical Examination 1Pemetrexed 1Immunotherapy, Adoptive 1Immunoenzyme Techniques 1Etoposide 1Cytarabine 1Craniospinal Irradiation 1Cisplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Carcinomatosis × Pemetrexed × Breast × Clear all
NCT06462092 2025-09-29

Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer

Guangzhou Medical University

Phase 1/2 Recruiting
34 enrolled
BreastCNS

Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡